Income StatementBalance SheetCash FlowSegments
Phillips 66 logo

Phillips 66 Cash Flow Statement

Operating, investing, and financing cash movements

Phillips 66 generated $2.5B in operating cash flow over the trailing twelve months. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$2.5BNet Cash From Investing (TTM)-$4.3BNet Cash From Financing (TTM)-$4.5BDepreciation And Amortization Cf (TTM)$3.0BNet Change In Cash (TTM)$3.7B
Latest FilingQ1 2026
Report Date2026-04-29
Market Cap$71.2B
P/E Ratio17.28
ROE14.78%

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other non-cash income (expense)-$147.0M$6.0M-$58.0M-$20.0M$141.0M$82.0M
Other non-cash income (expense)-$147.0M$6.0M-$58.0M-$20.0M$141.0M$82.0M
Change in accounts payable-$593.0M$384.0M$691.0M-$669.0M-$1.2B$3.0B
Change in inventories—$1.2B$393.0M$823.0M-$2.6B$1.7B
Change in receivables—-$901.0M$1.7B—$466.0M$2.5B
Deferred income taxes-$164.0M-$133.0M-$48.0M$14.0M$345.0M$67.0M
Depreciation and amortization$819.0M$791.0M$816.0M$826.0M$818.0M$558.0M
Unrealized Gain (Loss) on Equity Securities (FV-NI)$2.0M-$10.0M-$4.0M—-$2.0M-$9.0M
Other Non-Cash Income (Expense)-$147.0M$6.0M-$58.0M-$20.0M$141.0M$82.0M
Other Non-cash Income (Expense)-$147.0M$6.0M-$58.0M-$20.0M$141.0M$82.0M
Other Non-cash Income (Expense)-$147.0M$6.0M-$58.0M-$20.0M$141.0M$82.0M
Net cash from operating activities$1.2B$187.0M$845.0M$1.2B$2.8B-$2.3B
Net income$25.0M$526.0M$908.0M$167.0M$2.9B$219.0M
Other non-cash income (expense)-$147.0M$6.0M-$58.0M-$20.0M$141.0M$82.0M
Accretion Expense Including Asset Retirement Obligations$13.0M$12.0M$10.0M$12.0M$13.0M$12.0M
Asset write-downs$37.0M$26.0M$4.0M$951.0M$79.0M$8.0M
Gain (Loss) on Disposition of Other Assets$82.0M$1.1B$0.0$11.0M$2.0B$6.0M
Income Loss From Equity Method Investments Net Of Dividends Or Distributions—-$120.0M-$75.0M——$86.0M
Increase (Decrease) in Prepaid Expense and Other Assets-$102.0M$254.0M$172.0M$108.0M—$2.3B
Increase (Decrease) In Taxes And Other Accruals-$447.0M$111.0M$543.0M$57.0M—$470.0M
Other Noncash Income (Expense)-$147.0M$6.0M-$58.0M-$20.0M$141.0M$82.0M
Other Non-cash Income and Expense-$147.0M$6.0M-$58.0M-$20.0M$141.0M$82.0M
Other Non-Cash Adjustments-$147.0M$6.0M-$58.0M-$20.0M$141.0M$82.0M
Other Non-Cash Income and Expense-$147.0M$6.0M-$58.0M-$20.0M$141.0M$82.0M

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquisitions, net of cash acquired$58.0M$0.0$2.2B$0.0$1.3B$66.0M
Proceeds from Sales of Assets and Subsidiaries$176.0M$2.0B——$1.5B$7.0M
Capital Expenditures and Investments$506.0M$423.0M$587.0M$541.0M$682.0M$582.0M
Payment for (Proceeds from) Other Investing Activity—$45.0M-$57.0M-$28.0M—-$9.0M
Proceeds from disposition of property, plant and equipment/other$176.0M$2.0B——$1.5B$7.0M
Net cash from investing activities-$345.0M$1.6B-$2.7B-$487.0M-$467.0M-$606.0M
Dividend Received from Consumer Healthcare JV$19.0M$25.0M$18.0M$15.0M$32.0M$26.0M
Proceeds from sale of PPE and intangibles$176.0M$2.0B——$1.5B$7.0M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Proceeds from minority shareholders$0.0$0.0$106.0M$18.0M$8.0M$15.0M
Distributions to noncontrolling interests$24.0M$14.0M$81.0M$28.0M$41.0M$22.0M
Dividends paid$472.0M$469.0M$487.0M$484.0M$482.0M$509.0M
Proceeds from issuances of debt$1.1B$0.0$3.5B$2.5B$2.4B$9.6B
Other, net-$8.0M-$55.0M-$6.0M-$33.0M-$10.0M-$43.0M
Repayments of Debt and Lease Obligation$712.0M$1.3B$1.1B$1.6B$4.8B$2.0B
Net proceeds from sales of subsidiary shares$0.0$0.0$106.0M$18.0M$8.0M$15.0M
Payment of Deferred Purchase Consideration-$8.0M-$55.0M-$6.0M-$33.0M-$10.0M-$43.0M
Noncontrolling interest transactions and other-$8.0M-$55.0M-$6.0M-$33.0M-$10.0M-$43.0M
Proceeds from Minority Shareholders$0.0$0.0$106.0M$18.0M$8.0M$15.0M
Proceeds from Sale of Noncontrolling Interests$0.0$0.0$106.0M$18.0M$8.0M$15.0M
Net cash from financing activities-$724.0M-$2.0B——-$3.1B$6.9B
Noncontrolling Interests Activity and Other-$8.0M-$55.0M-$6.0M-$33.0M-$10.0M-$43.0M
Proceeds from Minority Shareholders$0.0$0.0$106.0M$18.0M$8.0M$15.0M
Proceeds from issuance of common stock$4.0M$23.0M$2.0M$68.0M$14.0M$84.0M
Repurchases of common stock$647.0M$247.0M$419.0M$267.0M$274.0M$269.0M
Proceeds from Minority Shareholders$0.0$0.0$106.0M$18.0M$8.0M$15.0M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$28.0M$22.0M$18.0M$3.0M$7.0M-$16.0M
Net increase (decrease) in cash—-$249.0M-$345.0M$806.0M-$834.0M$4.0B